nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbachol—PLA2G4A—Raltitrexed—Pemetrexed—lung cancer	0.0146	0.765	CbGdCrCtD
Carbachol—PLA2G4A—Raltitrexed—Methotrexate—lung cancer	0.00449	0.235	CbGdCrCtD
Carbachol—Hypotension—Teniposide—lung cancer	0.00185	0.00361	CcSEcCtD
Carbachol—Necrosis—Methotrexate—lung cancer	0.00184	0.0036	CcSEcCtD
Carbachol—Diarrhoea—Crizotinib—lung cancer	0.00183	0.00357	CcSEcCtD
Carbachol—Abscess—Methotrexate—lung cancer	0.00183	0.00357	CcSEcCtD
Carbachol—Arrhythmia—Erlotinib—lung cancer	0.00183	0.00357	CcSEcCtD
Carbachol—Sweating increased—Irinotecan—lung cancer	0.00177	0.00346	CcSEcCtD
Carbachol—Dizziness—Crizotinib—lung cancer	0.00177	0.00346	CcSEcCtD
Carbachol—Flatulence—Erlotinib—lung cancer	0.00175	0.00342	CcSEcCtD
Carbachol—Muscle spasms—Topotecan—lung cancer	0.00173	0.00338	CcSEcCtD
Carbachol—Hyponatraemia—Paclitaxel—lung cancer	0.00173	0.00337	CcSEcCtD
Carbachol—Cramp muscle—Cisplatin—lung cancer	0.00172	0.00336	CcSEcCtD
Carbachol—Vomiting—Crizotinib—lung cancer	0.0017	0.00332	CcSEcCtD
Carbachol—Phlebitis—Docetaxel—lung cancer	0.00169	0.0033	CcSEcCtD
Carbachol—Rash—Crizotinib—lung cancer	0.00169	0.00329	CcSEcCtD
Carbachol—Dermatitis—Crizotinib—lung cancer	0.00169	0.00329	CcSEcCtD
Carbachol—Diarrhoea—Pemetrexed—lung cancer	0.00167	0.00327	CcSEcCtD
Carbachol—Diarrhoea—Gefitinib—lung cancer	0.00166	0.00325	CcSEcCtD
Carbachol—Extravasation—Methotrexate—lung cancer	0.00166	0.00324	CcSEcCtD
Carbachol—Flushing—Vinorelbine—lung cancer	0.00164	0.0032	CcSEcCtD
Carbachol—Dizziness—Pemetrexed—lung cancer	0.00162	0.00316	CcSEcCtD
Carbachol—Sweating increased—Cisplatin—lung cancer	0.00161	0.00315	CcSEcCtD
Carbachol—Syncope—Erlotinib—lung cancer	0.0016	0.00312	CcSEcCtD
Carbachol—Necrosis—Doxorubicin—lung cancer	0.0016	0.00312	CcSEcCtD
Carbachol—Nausea—Crizotinib—lung cancer	0.00159	0.0031	CcSEcCtD
Carbachol—Abdominal discomfort—Cisplatin—lung cancer	0.00159	0.0031	CcSEcCtD
Carbachol—Abscess—Doxorubicin—lung cancer	0.00158	0.00309	CcSEcCtD
Carbachol—Arrhythmia—Vinorelbine—lung cancer	0.00158	0.00308	CcSEcCtD
Carbachol—Cramp muscle—Etoposide—lung cancer	0.00158	0.00308	CcSEcCtD
Carbachol—Body temperature increased—Teniposide—lung cancer	0.00157	0.00306	CcSEcCtD
Carbachol—Abdominal pain—Teniposide—lung cancer	0.00157	0.00306	CcSEcCtD
Carbachol—Loss of consciousness—Erlotinib—lung cancer	0.00156	0.00305	CcSEcCtD
Carbachol—Sweating—Irinotecan—lung cancer	0.00156	0.00304	CcSEcCtD
Carbachol—Vomiting—Pemetrexed—lung cancer	0.00156	0.00304	CcSEcCtD
Carbachol—Cramp muscle—Paclitaxel—lung cancer	0.00155	0.00302	CcSEcCtD
Carbachol—Stinging—Doxorubicin—lung cancer	0.00155	0.00302	CcSEcCtD
Carbachol—Vomiting—Gefitinib—lung cancer	0.00155	0.00302	CcSEcCtD
Carbachol—Rash—Pemetrexed—lung cancer	0.00154	0.00301	CcSEcCtD
Carbachol—Dermatitis—Pemetrexed—lung cancer	0.00154	0.00301	CcSEcCtD
Carbachol—Rash—Gefitinib—lung cancer	0.00153	0.00299	CcSEcCtD
Carbachol—Dermatitis—Gefitinib—lung cancer	0.00153	0.00299	CcSEcCtD
Carbachol—Ulcer—Methotrexate—lung cancer	0.00153	0.00299	CcSEcCtD
Carbachol—Sweating—Gemcitabine—lung cancer	0.00152	0.00296	CcSEcCtD
Carbachol—Sweating increased—Etoposide—lung cancer	0.00148	0.00288	CcSEcCtD
Carbachol—Hyponatraemia—Docetaxel—lung cancer	0.00146	0.00286	CcSEcCtD
Carbachol—Infection—Topotecan—lung cancer	0.00146	0.00285	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Docetaxel—lung cancer	0.00146	0.00284	CcSEcCtD
Carbachol—Nausea—Pemetrexed—lung cancer	0.00145	0.00284	CcSEcCtD
Carbachol—Sweating increased—Paclitaxel—lung cancer	0.00145	0.00283	CcSEcCtD
Carbachol—Nausea—Gefitinib—lung cancer	0.00144	0.00282	CcSEcCtD
Carbachol—Infection—Erlotinib—lung cancer	0.00144	0.00282	CcSEcCtD
Carbachol—Extravasation—Doxorubicin—lung cancer	0.00144	0.0028	CcSEcCtD
Carbachol—Shock—Erlotinib—lung cancer	0.00143	0.00279	CcSEcCtD
Carbachol—Hyperhidrosis—Topotecan—lung cancer	0.00142	0.00277	CcSEcCtD
Carbachol—Diarrhoea—Teniposide—lung cancer	0.00136	0.00265	CcSEcCtD
Carbachol—Flushing—Irinotecan—lung cancer	0.00135	0.00264	CcSEcCtD
Carbachol—Ulcer—Doxorubicin—lung cancer	0.00132	0.00259	CcSEcCtD
Carbachol—Cramp muscle—Docetaxel—lung cancer	0.00131	0.00256	CcSEcCtD
Carbachol—Arrhythmia—Irinotecan—lung cancer	0.0013	0.00254	CcSEcCtD
Carbachol—Pain—Vinblastine—lung cancer	0.00129	0.00252	CcSEcCtD
Carbachol—Dyspepsia—Topotecan—lung cancer	0.00129	0.00252	CcSEcCtD
Carbachol—Dyspepsia—Erlotinib—lung cancer	0.00128	0.0025	CcSEcCtD
Carbachol—Arrhythmia—Gemcitabine—lung cancer	0.00127	0.00248	CcSEcCtD
Carbachol—Vomiting—Teniposide—lung cancer	0.00126	0.00246	CcSEcCtD
Carbachol—Pain—Topotecan—lung cancer	0.00126	0.00245	CcSEcCtD
Carbachol—Flatulence—Irinotecan—lung cancer	0.00125	0.00244	CcSEcCtD
Carbachol—Rash—Teniposide—lung cancer	0.00125	0.00244	CcSEcCtD
Carbachol—Dermatitis—Teniposide—lung cancer	0.00125	0.00244	CcSEcCtD
Carbachol—Infection—Vinorelbine—lung cancer	0.00125	0.00244	CcSEcCtD
Carbachol—Pain—Erlotinib—lung cancer	0.00124	0.00243	CcSEcCtD
Carbachol—Headache—Teniposide—lung cancer	0.00124	0.00242	CcSEcCtD
Carbachol—Hyperkalaemia—Doxorubicin—lung cancer	0.00123	0.0024	CcSEcCtD
Carbachol—Flushing—Cisplatin—lung cancer	0.00123	0.0024	CcSEcCtD
Carbachol—Muscle spasms—Irinotecan—lung cancer	0.00122	0.00238	CcSEcCtD
Carbachol—Salivary hypersecretion—Doxorubicin—lung cancer	0.00122	0.00238	CcSEcCtD
Carbachol—Abdominal pain—Vinblastine—lung cancer	0.00119	0.00233	CcSEcCtD
Carbachol—Arrhythmia—Cisplatin—lung cancer	0.00118	0.00231	CcSEcCtD
Carbachol—Nausea—Teniposide—lung cancer	0.00118	0.0023	CcSEcCtD
Carbachol—Hypotension—Vinorelbine—lung cancer	0.00117	0.00229	CcSEcCtD
Carbachol—Abdominal pain—Topotecan—lung cancer	0.00116	0.00227	CcSEcCtD
Carbachol—Body temperature increased—Topotecan—lung cancer	0.00116	0.00227	CcSEcCtD
Carbachol—Abdominal pain—Erlotinib—lung cancer	0.00115	0.00224	CcSEcCtD
Carbachol—Body temperature increased—Erlotinib—lung cancer	0.00115	0.00224	CcSEcCtD
Carbachol—Syncope—Irinotecan—lung cancer	0.00114	0.00222	CcSEcCtD
Carbachol—Flatulence—Cisplatin—lung cancer	0.00114	0.00222	CcSEcCtD
Carbachol—Flushing—Etoposide—lung cancer	0.00113	0.0022	CcSEcCtD
Carbachol—Loss of consciousness—Irinotecan—lung cancer	0.00112	0.00218	CcSEcCtD
Carbachol—Muscle spasms—Cisplatin—lung cancer	0.00111	0.00216	CcSEcCtD
Carbachol—Flushing—Paclitaxel—lung cancer	0.0011	0.00215	CcSEcCtD
Carbachol—Pain—Vinorelbine—lung cancer	0.00107	0.0021	CcSEcCtD
Carbachol—Arrhythmia—Paclitaxel—lung cancer	0.00106	0.00207	CcSEcCtD
Carbachol—Phlebitis—Doxorubicin—lung cancer	0.00106	0.00206	CcSEcCtD
Carbachol—Diarrhoea—Vinblastine—lung cancer	0.00103	0.00202	CcSEcCtD
Carbachol—Infection—Irinotecan—lung cancer	0.00103	0.00201	CcSEcCtD
Carbachol—Flatulence—Paclitaxel—lung cancer	0.00102	0.00199	CcSEcCtD
Carbachol—Shock—Irinotecan—lung cancer	0.00102	0.00199	CcSEcCtD
Carbachol—Muscle spasms—Etoposide—lung cancer	0.00102	0.00198	CcSEcCtD
Carbachol—Diarrhoea—Topotecan—lung cancer	0.001	0.00196	CcSEcCtD
Carbachol—Infection—Gemcitabine—lung cancer	0.001	0.00196	CcSEcCtD
Carbachol—Hyperhidrosis—Irinotecan—lung cancer	0.001	0.00196	CcSEcCtD
Carbachol—Dizziness—Vinblastine—lung cancer	0.001	0.00195	CcSEcCtD
Carbachol—Muscle spasms—Paclitaxel—lung cancer	0.000995	0.00194	CcSEcCtD
Carbachol—Diarrhoea—Erlotinib—lung cancer	0.000994	0.00194	CcSEcCtD
Carbachol—Body temperature increased—Vinorelbine—lung cancer	0.000993	0.00194	CcSEcCtD
Carbachol—Abdominal pain—Vinorelbine—lung cancer	0.000993	0.00194	CcSEcCtD
Carbachol—Hyperhidrosis—Gemcitabine—lung cancer	0.000976	0.0019	CcSEcCtD
Carbachol—Dizziness—Topotecan—lung cancer	0.000971	0.0019	CcSEcCtD
Carbachol—Hypotension—Irinotecan—lung cancer	0.000968	0.00189	CcSEcCtD
Carbachol—Vomiting—Vinblastine—lung cancer	0.000961	0.00188	CcSEcCtD
Carbachol—Dizziness—Erlotinib—lung cancer	0.000961	0.00188	CcSEcCtD
Carbachol—Headache—Vinblastine—lung cancer	0.000947	0.00185	CcSEcCtD
Carbachol—Hypotension—Gemcitabine—lung cancer	0.000943	0.00184	CcSEcCtD
Carbachol—Flushing—Docetaxel—lung cancer	0.000936	0.00183	CcSEcCtD
Carbachol—Infection—Cisplatin—lung cancer	0.000935	0.00182	CcSEcCtD
Carbachol—Vomiting—Topotecan—lung cancer	0.000934	0.00182	CcSEcCtD
Carbachol—Syncope—Paclitaxel—lung cancer	0.000928	0.00181	CcSEcCtD
Carbachol—Loss of consciousness—Etoposide—lung cancer	0.000928	0.00181	CcSEcCtD
Carbachol—Rash—Topotecan—lung cancer	0.000926	0.00181	CcSEcCtD
Carbachol—Dermatitis—Topotecan—lung cancer	0.000925	0.00181	CcSEcCtD
Carbachol—Vomiting—Erlotinib—lung cancer	0.000924	0.0018	CcSEcCtD
Carbachol—Headache—Topotecan—lung cancer	0.00092	0.0018	CcSEcCtD
Carbachol—Rash—Erlotinib—lung cancer	0.000916	0.00179	CcSEcCtD
Carbachol—Dermatitis—Erlotinib—lung cancer	0.000915	0.00179	CcSEcCtD
Carbachol—Hyponatraemia—Doxorubicin—lung cancer	0.000913	0.00178	CcSEcCtD
Carbachol—Dyspepsia—Irinotecan—lung cancer	0.000912	0.00178	CcSEcCtD
Carbachol—Headache—Erlotinib—lung cancer	0.00091	0.00178	CcSEcCtD
Carbachol—Loss of consciousness—Paclitaxel—lung cancer	0.00091	0.00178	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Doxorubicin—lung cancer	0.000909	0.00178	CcSEcCtD
Carbachol—Hyperhidrosis—Cisplatin—lung cancer	0.000909	0.00178	CcSEcCtD
Carbachol—Asthma—Methotrexate—lung cancer	0.000908	0.00177	CcSEcCtD
Carbachol—Arrhythmia—Docetaxel—lung cancer	0.000901	0.00176	CcSEcCtD
Carbachol—Nausea—Vinblastine—lung cancer	0.000898	0.00175	CcSEcCtD
Carbachol—Pain—Irinotecan—lung cancer	0.000886	0.00173	CcSEcCtD
Carbachol—Hypotension—Cisplatin—lung cancer	0.000879	0.00172	CcSEcCtD
Carbachol—Nausea—Topotecan—lung cancer	0.000872	0.0017	CcSEcCtD
Carbachol—Abdominal discomfort—Methotrexate—lung cancer	0.00087	0.0017	CcSEcCtD
Carbachol—Pain—Gemcitabine—lung cancer	0.000863	0.00168	CcSEcCtD
Carbachol—Nausea—Erlotinib—lung cancer	0.000863	0.00168	CcSEcCtD
Carbachol—Diarrhoea—Vinorelbine—lung cancer	0.00086	0.00168	CcSEcCtD
Carbachol—Infection—Etoposide—lung cancer	0.000856	0.00167	CcSEcCtD
Carbachol—Muscle spasms—Docetaxel—lung cancer	0.000844	0.00165	CcSEcCtD
Carbachol—Infection—Paclitaxel—lung cancer	0.000839	0.00164	CcSEcCtD
Carbachol—Hyperhidrosis—Etoposide—lung cancer	0.000833	0.00163	CcSEcCtD
Carbachol—Shock—Paclitaxel—lung cancer	0.000831	0.00162	CcSEcCtD
Carbachol—Dizziness—Vinorelbine—lung cancer	0.000831	0.00162	CcSEcCtD
Carbachol—Abdominal pain—Irinotecan—lung cancer	0.000819	0.0016	CcSEcCtD
Carbachol—Body temperature increased—Irinotecan—lung cancer	0.000819	0.0016	CcSEcCtD
Carbachol—Hyperhidrosis—Paclitaxel—lung cancer	0.000817	0.00159	CcSEcCtD
Carbachol—Hypotension—Etoposide—lung cancer	0.000805	0.00157	CcSEcCtD
Carbachol—Pain—Cisplatin—lung cancer	0.000804	0.00157	CcSEcCtD
Carbachol—Vomiting—Vinorelbine—lung cancer	0.000799	0.00156	CcSEcCtD
Carbachol—Body temperature increased—Gemcitabine—lung cancer	0.000798	0.00156	CcSEcCtD
Carbachol—Rash—Vinorelbine—lung cancer	0.000792	0.00155	CcSEcCtD
Carbachol—Dermatitis—Vinorelbine—lung cancer	0.000791	0.00154	CcSEcCtD
Carbachol—Hypotension—Paclitaxel—lung cancer	0.00079	0.00154	CcSEcCtD
Carbachol—Headache—Vinorelbine—lung cancer	0.000787	0.00154	CcSEcCtD
Carbachol—Syncope—Docetaxel—lung cancer	0.000787	0.00154	CcSEcCtD
Carbachol—Asthma—Doxorubicin—lung cancer	0.000786	0.00153	CcSEcCtD
Carbachol—Sweating—Methotrexate—lung cancer	0.000776	0.00151	CcSEcCtD
Carbachol—Loss of consciousness—Docetaxel—lung cancer	0.000771	0.00151	CcSEcCtD
Carbachol—Nausea—Vinorelbine—lung cancer	0.000746	0.00146	CcSEcCtD
Carbachol—Dyspepsia—Paclitaxel—lung cancer	0.000744	0.00145	CcSEcCtD
Carbachol—Body temperature increased—Cisplatin—lung cancer	0.000744	0.00145	CcSEcCtD
Carbachol—Pain—Etoposide—lung cancer	0.000737	0.00144	CcSEcCtD
Carbachol—Pain—Paclitaxel—lung cancer	0.000723	0.00141	CcSEcCtD
Carbachol—Infection—Docetaxel—lung cancer	0.000712	0.00139	CcSEcCtD
Carbachol—Diarrhoea—Irinotecan—lung cancer	0.000709	0.00138	CcSEcCtD
Carbachol—Shock—Docetaxel—lung cancer	0.000705	0.00138	CcSEcCtD
Carbachol—Diarrhoea—Gemcitabine—lung cancer	0.000691	0.00135	CcSEcCtD
Carbachol—Dizziness—Irinotecan—lung cancer	0.000685	0.00134	CcSEcCtD
Carbachol—Abdominal pain—Etoposide—lung cancer	0.000681	0.00133	CcSEcCtD
Carbachol—Body temperature increased—Etoposide—lung cancer	0.000681	0.00133	CcSEcCtD
Carbachol—Sweating—Doxorubicin—lung cancer	0.000672	0.00131	CcSEcCtD
Carbachol—Hypotension—Docetaxel—lung cancer	0.000669	0.00131	CcSEcCtD
Carbachol—Abdominal pain—Paclitaxel—lung cancer	0.000668	0.0013	CcSEcCtD
Carbachol—Body temperature increased—Paclitaxel—lung cancer	0.000668	0.0013	CcSEcCtD
Carbachol—Vomiting—Irinotecan—lung cancer	0.000659	0.00129	CcSEcCtD
Carbachol—Rash—Irinotecan—lung cancer	0.000653	0.00128	CcSEcCtD
Carbachol—Dermatitis—Irinotecan—lung cancer	0.000653	0.00127	CcSEcCtD
Carbachol—Headache—Irinotecan—lung cancer	0.000649	0.00127	CcSEcCtD
Carbachol—Diarrhoea—Cisplatin—lung cancer	0.000644	0.00126	CcSEcCtD
Carbachol—Vomiting—Gemcitabine—lung cancer	0.000642	0.00125	CcSEcCtD
Carbachol—Rash—Gemcitabine—lung cancer	0.000636	0.00124	CcSEcCtD
Carbachol—Dermatitis—Gemcitabine—lung cancer	0.000636	0.00124	CcSEcCtD
Carbachol—Headache—Gemcitabine—lung cancer	0.000632	0.00123	CcSEcCtD
Carbachol—Dyspepsia—Docetaxel—lung cancer	0.00063	0.00123	CcSEcCtD
Carbachol—Nausea—Irinotecan—lung cancer	0.000615	0.0012	CcSEcCtD
Carbachol—Pain—Docetaxel—lung cancer	0.000612	0.0012	CcSEcCtD
Carbachol—Nausea—Gemcitabine—lung cancer	0.000599	0.00117	CcSEcCtD
Carbachol—Vomiting—Cisplatin—lung cancer	0.000598	0.00117	CcSEcCtD
Carbachol—Rash—Cisplatin—lung cancer	0.000593	0.00116	CcSEcCtD
Carbachol—Dermatitis—Cisplatin—lung cancer	0.000593	0.00116	CcSEcCtD
Carbachol—Diarrhoea—Etoposide—lung cancer	0.00059	0.00115	CcSEcCtD
Carbachol—Flushing—Doxorubicin—lung cancer	0.000584	0.00114	CcSEcCtD
Carbachol—Diarrhoea—Paclitaxel—lung cancer	0.000578	0.00113	CcSEcCtD
Carbachol—Dizziness—Etoposide—lung cancer	0.00057	0.00111	CcSEcCtD
Carbachol—Body temperature increased—Docetaxel—lung cancer	0.000566	0.00111	CcSEcCtD
Carbachol—Abdominal pain—Docetaxel—lung cancer	0.000566	0.00111	CcSEcCtD
Carbachol—Arrhythmia—Doxorubicin—lung cancer	0.000562	0.0011	CcSEcCtD
Carbachol—Dizziness—Paclitaxel—lung cancer	0.000559	0.00109	CcSEcCtD
Carbachol—Nausea—Cisplatin—lung cancer	0.000559	0.00109	CcSEcCtD
Carbachol—Vomiting—Etoposide—lung cancer	0.000548	0.00107	CcSEcCtD
Carbachol—Rash—Etoposide—lung cancer	0.000543	0.00106	CcSEcCtD
Carbachol—Dermatitis—Etoposide—lung cancer	0.000543	0.00106	CcSEcCtD
Carbachol—Headache—Etoposide—lung cancer	0.00054	0.00105	CcSEcCtD
Carbachol—Flatulence—Doxorubicin—lung cancer	0.00054	0.00105	CcSEcCtD
Carbachol—Vomiting—Paclitaxel—lung cancer	0.000537	0.00105	CcSEcCtD
Carbachol—Rash—Paclitaxel—lung cancer	0.000533	0.00104	CcSEcCtD
Carbachol—Dermatitis—Paclitaxel—lung cancer	0.000532	0.00104	CcSEcCtD
Carbachol—Headache—Paclitaxel—lung cancer	0.000529	0.00103	CcSEcCtD
Carbachol—Muscle spasms—Doxorubicin—lung cancer	0.000527	0.00103	CcSEcCtD
Carbachol—Infection—Methotrexate—lung cancer	0.000513	0.001	CcSEcCtD
Carbachol—Nausea—Etoposide—lung cancer	0.000512	0.000999	CcSEcCtD
Carbachol—Nausea—Paclitaxel—lung cancer	0.000502	0.00098	CcSEcCtD
Carbachol—Hyperhidrosis—Methotrexate—lung cancer	0.000499	0.000974	CcSEcCtD
Carbachol—Syncope—Doxorubicin—lung cancer	0.000491	0.000959	CcSEcCtD
Carbachol—Diarrhoea—Docetaxel—lung cancer	0.00049	0.000957	CcSEcCtD
Carbachol—Hypotension—Methotrexate—lung cancer	0.000482	0.000942	CcSEcCtD
Carbachol—Loss of consciousness—Doxorubicin—lung cancer	0.000481	0.00094	CcSEcCtD
Carbachol—Dizziness—Docetaxel—lung cancer	0.000474	0.000925	CcSEcCtD
Carbachol—Vomiting—Docetaxel—lung cancer	0.000455	0.000889	CcSEcCtD
Carbachol—Dyspepsia—Methotrexate—lung cancer	0.000454	0.000887	CcSEcCtD
Carbachol—Rash—Docetaxel—lung cancer	0.000452	0.000882	CcSEcCtD
Carbachol—Dermatitis—Docetaxel—lung cancer	0.000451	0.000881	CcSEcCtD
Carbachol—Headache—Docetaxel—lung cancer	0.000449	0.000876	CcSEcCtD
Carbachol—Infection—Doxorubicin—lung cancer	0.000444	0.000867	CcSEcCtD
Carbachol—Pain—Methotrexate—lung cancer	0.000441	0.000862	CcSEcCtD
Carbachol—Shock—Doxorubicin—lung cancer	0.00044	0.000858	CcSEcCtD
Carbachol—Hyperhidrosis—Doxorubicin—lung cancer	0.000432	0.000844	CcSEcCtD
Carbachol—Nausea—Docetaxel—lung cancer	0.000425	0.00083	CcSEcCtD
Carbachol—Hypotension—Doxorubicin—lung cancer	0.000418	0.000815	CcSEcCtD
Carbachol—Abdominal pain—Methotrexate—lung cancer	0.000408	0.000797	CcSEcCtD
Carbachol—Body temperature increased—Methotrexate—lung cancer	0.000408	0.000797	CcSEcCtD
Carbachol—Dyspepsia—Doxorubicin—lung cancer	0.000393	0.000768	CcSEcCtD
Carbachol—Pain—Doxorubicin—lung cancer	0.000382	0.000746	CcSEcCtD
Carbachol—Body temperature increased—Doxorubicin—lung cancer	0.000353	0.00069	CcSEcCtD
Carbachol—Abdominal pain—Doxorubicin—lung cancer	0.000353	0.00069	CcSEcCtD
Carbachol—Diarrhoea—Methotrexate—lung cancer	0.000353	0.000689	CcSEcCtD
Carbachol—Dizziness—Methotrexate—lung cancer	0.000341	0.000666	CcSEcCtD
Carbachol—Vomiting—Methotrexate—lung cancer	0.000328	0.000641	CcSEcCtD
Carbachol—Rash—Methotrexate—lung cancer	0.000325	0.000635	CcSEcCtD
Carbachol—Dermatitis—Methotrexate—lung cancer	0.000325	0.000635	CcSEcCtD
Carbachol—Headache—Methotrexate—lung cancer	0.000323	0.000631	CcSEcCtD
Carbachol—Nausea—Methotrexate—lung cancer	0.000307	0.000599	CcSEcCtD
Carbachol—Diarrhoea—Doxorubicin—lung cancer	0.000306	0.000597	CcSEcCtD
Carbachol—Dizziness—Doxorubicin—lung cancer	0.000296	0.000577	CcSEcCtD
Carbachol—Vomiting—Doxorubicin—lung cancer	0.000284	0.000555	CcSEcCtD
Carbachol—Rash—Doxorubicin—lung cancer	0.000282	0.00055	CcSEcCtD
Carbachol—Dermatitis—Doxorubicin—lung cancer	0.000282	0.00055	CcSEcCtD
Carbachol—Headache—Doxorubicin—lung cancer	0.00028	0.000547	CcSEcCtD
Carbachol—Nausea—Doxorubicin—lung cancer	0.000265	0.000518	CcSEcCtD
Carbachol—CHRM3—Metabolism—CYP1A1—lung cancer	4.48e-05	9.55e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—EGFR—lung cancer	4.46e-05	9.52e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PTGS2—lung cancer	4.44e-05	9.48e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ERCC2—lung cancer	4.44e-05	9.47e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—FOXO3—lung cancer	4.44e-05	9.47e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—MAP2K1—lung cancer	4.41e-05	9.4e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—MAP2K1—lung cancer	4.39e-05	9.37e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PIK3CD—lung cancer	4.38e-05	9.34e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PIK3CD—lung cancer	4.36e-05	9.31e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—MAP2K1—lung cancer	4.35e-05	9.28e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MAP2K1—lung cancer	4.33e-05	9.24e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PIK3CD—lung cancer	4.32e-05	9.22e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PIK3CD—lung cancer	4.3e-05	9.18e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AVP—lung cancer	4.21e-05	8.99e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—KRAS—lung cancer	4.21e-05	8.99e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—PIK3CB—lung cancer	4.2e-05	8.97e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AVP—lung cancer	4.2e-05	8.96e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—PIK3CB—lung cancer	4.19e-05	8.94e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AVP—lung cancer	4.16e-05	8.88e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—PIK3CB—lung cancer	4.15e-05	8.85e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IGF1R—lung cancer	4.06e-05	8.65e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IGF1R—lung cancer	4.04e-05	8.63e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—CXCL8—lung cancer	4.04e-05	8.62e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—CXCL8—lung cancer	4.03e-05	8.59e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IGF1R—lung cancer	4e-05	8.54e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—CXCL8—lung cancer	3.99e-05	8.51e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HES1—lung cancer	3.98e-05	8.5e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HES1—lung cancer	3.97e-05	8.48e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HES1—lung cancer	3.93e-05	8.39e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—RAF1—lung cancer	3.91e-05	8.34e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—RAF1—lung cancer	3.9e-05	8.31e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PTEN—lung cancer	3.88e-05	8.27e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—PIK3CA—lung cancer	3.87e-05	8.26e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—IL2—lung cancer	3.86e-05	8.23e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—RAF1—lung cancer	3.86e-05	8.23e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MDM2—lung cancer	3.86e-05	8.23e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—IL2—lung cancer	3.85e-05	8.21e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—RAF1—lung cancer	3.84e-05	8.2e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—APOA1—lung cancer	3.84e-05	8.2e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PIK3CB—lung cancer	3.82e-05	8.14e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—IL2—lung cancer	3.81e-05	8.13e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PIK3CB—lung cancer	3.8e-05	8.12e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—ERBB2—lung cancer	3.8e-05	8.11e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PIK3CB—lung cancer	3.77e-05	8.04e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MTOR—lung cancer	3.75e-05	8e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PIK3CB—lung cancer	3.75e-05	8e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—EP300—lung cancer	3.7e-05	7.89e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CXCL8—lung cancer	3.67e-05	7.82e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CXCL8—lung cancer	3.66e-05	7.8e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ERBB3—lung cancer	3.64e-05	7.77e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ERBB3—lung cancer	3.63e-05	7.75e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CXCL8—lung cancer	3.62e-05	7.72e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CXCL8—lung cancer	3.6e-05	7.69e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ERBB3—lung cancer	3.6e-05	7.67e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—HRAS—lung cancer	3.58e-05	7.64e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3CG—lung cancer	3.51e-05	7.48e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—IL2—lung cancer	3.5e-05	7.48e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—IL2—lung cancer	3.49e-05	7.45e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TERT—lung cancer	3.49e-05	7.45e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TERT—lung cancer	3.48e-05	7.43e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—IL2—lung cancer	3.46e-05	7.38e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CASP3—lung cancer	3.45e-05	7.36e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TERT—lung cancer	3.45e-05	7.35e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IL2—lung cancer	3.44e-05	7.35e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—IL6—lung cancer	3.43e-05	7.31e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—FGFR1—lung cancer	3.39e-05	7.23e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—FGFR1—lung cancer	3.38e-05	7.21e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CCND1—lung cancer	3.36e-05	7.16e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—JUN—lung cancer	3.35e-05	7.15e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—FGFR1—lung cancer	3.35e-05	7.14e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HIF1A—lung cancer	3.34e-05	7.12e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—POMC—lung cancer	3.34e-05	7.12e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HIF1A—lung cancer	3.33e-05	7.1e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HIF1A—lung cancer	3.3e-05	7.03e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MMP9—lung cancer	3.26e-05	6.96e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CREBBP—lung cancer	3.25e-05	6.94e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CDKN1A—lung cancer	3.25e-05	6.93e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PTEN—lung cancer	3.24e-05	6.92e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—APOA1—lung cancer	3.22e-05	6.88e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—APOA1—lung cancer	3.21e-05	6.85e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—KDR—lung cancer	3.19e-05	6.81e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—KDR—lung cancer	3.18e-05	6.79e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—APOA1—lung cancer	3.18e-05	6.79e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—AKT1—lung cancer	3.16e-05	6.75e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—KDR—lung cancer	3.15e-05	6.73e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—EP300—lung cancer	3.09e-05	6.6e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3CD—lung cancer	3.08e-05	6.58e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ALB—lung cancer	3.04e-05	6.49e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—SRC—lung cancer	3.01e-05	6.41e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—KIT—lung cancer	2.94e-05	6.28e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—APC—lung cancer	2.94e-05	6.28e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3CG—lung cancer	2.94e-05	6.28e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—NRAS—lung cancer	2.94e-05	6.28e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—APC—lung cancer	2.93e-05	6.26e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—KIT—lung cancer	2.93e-05	6.26e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3CG—lung cancer	2.93e-05	6.26e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—NRAS—lung cancer	2.93e-05	6.26e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—VEGFA—lung cancer	2.93e-05	6.25e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—EGF—lung cancer	2.91e-05	6.2e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—APC—lung cancer	2.9e-05	6.2e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—KIT—lung cancer	2.9e-05	6.2e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3CG—lung cancer	2.9e-05	6.2e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—NRAS—lung cancer	2.9e-05	6.2e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—STAT3—lung cancer	2.9e-05	6.18e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—EGF—lung cancer	2.9e-05	6.18e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—NRAS—lung cancer	2.89e-05	6.17e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—EGF—lung cancer	2.87e-05	6.12e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—MAPK3—lung cancer	2.82e-05	6.01e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—MAPK3—lung cancer	2.81e-05	5.99e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—POMC—lung cancer	2.8e-05	5.97e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—POMC—lung cancer	2.79e-05	5.96e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—MAPK3—lung cancer	2.78e-05	5.93e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MAPK3—lung cancer	2.77e-05	5.91e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—BRAF—lung cancer	2.77e-05	5.9e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—POMC—lung cancer	2.76e-05	5.9e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—BRAF—lung cancer	2.76e-05	5.88e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PIK3CA—lung cancer	2.73e-05	5.83e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL6R—lung cancer	2.73e-05	5.83e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—BRAF—lung cancer	2.73e-05	5.82e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CREBBP—lung cancer	2.73e-05	5.82e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL6R—lung cancer	2.72e-05	5.81e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CREBBP—lung cancer	2.72e-05	5.8e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL6R—lung cancer	2.7e-05	5.75e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MYC—lung cancer	2.69e-05	5.75e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CREBBP—lung cancer	2.69e-05	5.74e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3CB—lung cancer	2.69e-05	5.73e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—EGFR—lung cancer	2.68e-05	5.72e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—EGFR—lung cancer	2.67e-05	5.7e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PTGS2—lung cancer	2.66e-05	5.68e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—EGFR—lung cancer	2.65e-05	5.65e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—EGFR—lung cancer	2.63e-05	5.62e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MAP2K1—lung cancer	2.6e-05	5.55e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MAP2K1—lung cancer	2.6e-05	5.54e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3CD—lung cancer	2.59e-05	5.52e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3CD—lung cancer	2.58e-05	5.5e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MAP2K1—lung cancer	2.57e-05	5.48e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—PIK3CA—lung cancer	2.56e-05	5.47e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—PIK3CA—lung cancer	2.55e-05	5.45e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3CD—lung cancer	2.55e-05	5.45e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—KRAS—lung cancer	2.53e-05	5.4e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—PIK3CA—lung cancer	2.53e-05	5.4e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—KRAS—lung cancer	2.52e-05	5.39e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—KRAS—lung cancer	2.5e-05	5.33e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—KRAS—lung cancer	2.49e-05	5.31e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PIK3CA—lung cancer	2.33e-05	4.96e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PTEN—lung cancer	2.32e-05	4.95e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PIK3CA—lung cancer	2.32e-05	4.95e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MDM2—lung cancer	2.32e-05	4.94e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MDM2—lung cancer	2.31e-05	4.93e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—RAF1—lung cancer	2.31e-05	4.93e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—RAF1—lung cancer	2.3e-05	4.91e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PIK3CA—lung cancer	2.3e-05	4.9e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MDM2—lung cancer	2.29e-05	4.88e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PIK3CA—lung cancer	2.29e-05	4.88e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ERBB2—lung cancer	2.28e-05	4.87e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—RAF1—lung cancer	2.28e-05	4.86e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ERBB2—lung cancer	2.28e-05	4.86e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ERBB2—lung cancer	2.25e-05	4.81e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3CB—lung cancer	2.25e-05	4.81e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MTOR—lung cancer	2.25e-05	4.81e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3CB—lung cancer	2.25e-05	4.79e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MTOR—lung cancer	2.25e-05	4.79e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—AKT1—lung cancer	2.23e-05	4.77e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MTOR—lung cancer	2.23e-05	4.75e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3CB—lung cancer	2.23e-05	4.75e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—EP300—lung cancer	2.21e-05	4.73e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TP53—lung cancer	2.21e-05	4.72e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CXCL8—lung cancer	2.17e-05	4.62e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CXCL8—lung cancer	2.16e-05	4.61e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—HRAS—lung cancer	2.15e-05	4.59e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—HRAS—lung cancer	2.15e-05	4.58e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CXCL8—lung cancer	2.14e-05	4.56e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—HRAS—lung cancer	2.12e-05	4.53e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—HRAS—lung cancer	2.12e-05	4.51e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—AKT1—lung cancer	2.09e-05	4.46e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—AKT1—lung cancer	2.09e-05	4.45e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CASP3—lung cancer	2.07e-05	4.42e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL2—lung cancer	2.07e-05	4.42e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CASP3—lung cancer	2.07e-05	4.41e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—AKT1—lung cancer	2.07e-05	4.41e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL2—lung cancer	2.06e-05	4.4e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—IL6—lung cancer	2.06e-05	4.4e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—IL6—lung cancer	2.05e-05	4.38e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CASP3—lung cancer	2.05e-05	4.37e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL2—lung cancer	2.04e-05	4.36e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—IL6—lung cancer	2.03e-05	4.34e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IL6—lung cancer	2.02e-05	4.32e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CCND1—lung cancer	2.02e-05	4.31e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—JUN—lung cancer	2.01e-05	4.3e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CCND1—lung cancer	2.01e-05	4.29e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—JUN—lung cancer	2.01e-05	4.28e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CCND1—lung cancer	1.99e-05	4.25e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—JUN—lung cancer	1.99e-05	4.24e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MMP9—lung cancer	1.96e-05	4.18e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MMP9—lung cancer	1.95e-05	4.17e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CDKN1A—lung cancer	1.95e-05	4.17e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PTEN—lung cancer	1.95e-05	4.16e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CDKN1A—lung cancer	1.95e-05	4.15e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PTEN—lung cancer	1.94e-05	4.14e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MMP9—lung cancer	1.93e-05	4.13e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CDKN1A—lung cancer	1.93e-05	4.11e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PTEN—lung cancer	1.92e-05	4.1e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—AKT1—lung cancer	1.9e-05	4.05e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—AKT1—lung cancer	1.89e-05	4.04e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—AKT1—lung cancer	1.88e-05	4e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—AKT1—lung cancer	1.87e-05	3.99e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—EP300—lung cancer	1.86e-05	3.96e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—EP300—lung cancer	1.85e-05	3.95e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—EP300—lung cancer	1.83e-05	3.91e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SRC—lung cancer	1.81e-05	3.85e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SRC—lung cancer	1.8e-05	3.84e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SRC—lung cancer	1.78e-05	3.8e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—VEGFA—lung cancer	1.76e-05	3.75e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—VEGFA—lung cancer	1.75e-05	3.74e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—STAT3—lung cancer	1.74e-05	3.72e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NRAS—lung cancer	1.74e-05	3.71e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—VEGFA—lung cancer	1.74e-05	3.71e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—STAT3—lung cancer	1.74e-05	3.71e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NRAS—lung cancer	1.73e-05	3.7e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—STAT3—lung cancer	1.72e-05	3.67e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NRAS—lung cancer	1.72e-05	3.66e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MAPK3—lung cancer	1.66e-05	3.55e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MAPK3—lung cancer	1.66e-05	3.54e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MAPK3—lung cancer	1.64e-05	3.51e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3CA—lung cancer	1.64e-05	3.5e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MYC—lung cancer	1.62e-05	3.45e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MYC—lung cancer	1.61e-05	3.44e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MYC—lung cancer	1.6e-05	3.41e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—EGFR—lung cancer	1.58e-05	3.38e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—EGFR—lung cancer	1.58e-05	3.37e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—EGFR—lung cancer	1.56e-05	3.33e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—KRAS—lung cancer	1.5e-05	3.19e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—KRAS—lung cancer	1.49e-05	3.18e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—KRAS—lung cancer	1.48e-05	3.15e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3CA—lung cancer	1.37e-05	2.93e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3CA—lung cancer	1.37e-05	2.92e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3CA—lung cancer	1.36e-05	2.89e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—AKT1—lung cancer	1.34e-05	2.86e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TP53—lung cancer	1.33e-05	2.84e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TP53—lung cancer	1.33e-05	2.83e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TP53—lung cancer	1.31e-05	2.8e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HRAS—lung cancer	1.27e-05	2.71e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HRAS—lung cancer	1.27e-05	2.7e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HRAS—lung cancer	1.26e-05	2.68e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL6—lung cancer	1.22e-05	2.6e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL6—lung cancer	1.21e-05	2.59e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL6—lung cancer	1.2e-05	2.56e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AKT1—lung cancer	1.12e-05	2.4e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AKT1—lung cancer	1.12e-05	2.39e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AKT1—lung cancer	1.11e-05	2.36e-05	CbGpPWpGaD
